18F-DCFPyL PET/CT

DIAGNOSTIC_TEST5 trials

Sponsors

Sir Mortimer B. Davis - Jewish General Hospital, Grand River Hospital, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, British Columbia Cancer Agency

Conditions

Carcinoid TumorNeuroblastomaNeuroendocrine TumorsParagangliomaProstate CancerProstatic Neoplasms

Phase 1

Assessment of Multi-Modality Quantitative Imaging for Evaluation of Response of Metastatic Prostate Cancer to Therapy

TerminatedNCT03619655

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsProstate Cancer

Start: 2019-11-15End: 2022-11-14Updated: 2023-10-31

Phase 2

Correlation Between SUV on 18F-DCFPyL PET/CT and Gleason Score in Prostate Cancer

CompletedNCT03001895

Sir Mortimer B. Davis - Jewish General HospitalProstate Cancer

Start: 2017-07-01End: 2018-10-05Updated: 2019-02-15

Prostate Cancer Patient Management With 18F-DCFPyL PET/CT

Enrolling by invitationNCT03459820

Sir Mortimer B. Davis - Jewish General HospitalProstate Cancer

Start: 2018-06-22End: 2028-06-30Target: 1500Updated: 2023-11-27

Unknown Phase

PSMA-based 18F-DCFPyL PET/CT: Evaluating Its Application in Real Life

Grand River HospitalProstate Cancer

Start: 2018-08-10End: 2019-12-31Target: 12Updated: 2019-02-15

Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging

British Columbia Cancer AgencyCarcinoid Tumor, Neuroblastoma, Neuroendocrine Tumors +3

Start: 2019-11-01End: 2024-08-01Target: 60Updated: 2021-01-26